During the forecast period from 2023 to 2033, the Global Birch Allergy Treatment Industry is poised for substantial growth at a 7% Compound Annual Growth Rate (CAGR), as reported by Future Market Insights. By the year 2033, the global market for Birch allergy treatment is expected to reach a remarkable valuation of US$ 1123.24 Million.
The escalating awareness surrounding allergies and their profound impact on health is a key driver behind the market’s anticipated growth. The rise in the prevalence of allergic reactions has prompted healthcare providers to intensify their focus on allergy prevention and treatment. This trend has led to a surge in individuals seeking medical intervention for various allergies, including those triggered by birch pollen.
Request a Sample of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-16769
In addition to traditional treatment options, there has also been a growing interest in alternative therapies for the treatment of birch allergy. These therapies include acupuncture, herbal remedies, and homeopathy. While the efficacy of these treatments is still being studied, they have shown promising results in some cases and may provide additional treatment options for birch allergy sufferers.
Key Takeaways from the Global Birch Allergy Treatment Industry Study
- The Birch allergy treatment market is expected to grow at a value of 7% CAGR in the forecast period 2023-2033
- Oral route of administration is expected to hold 53% of the market share in 2023 for Birch allergy treatment market.
- North America is expected to possess 48% market share for Birch allergy treatment market in 2023.
- Europe Birch allergy treatment market size is expected to possess 43% market share in 2023.
“Significant increase in the number of drugs and therapies available for the treatment of birch allergy is not only increasing treatment options for patients but has also has made treatments more effective and efficient.” states an FMI analyst
Reach Out to Our Analyst For Your Queries https://www.futuremarketinsights.com/ask-question/rep-gb-16769
Global Birch Allergy Treatment Industry Competitive Landscape
Key players in the Birch allergy treatment market are Allergy Therapeutics Plc, Regeneron Pharmaceuticals Inc, Desentum, HAL Allergy Group, Roxall Medizin GmbH, Worg Pharmaceuticals AG, S-TARget therapeutics GmbH, Adamis Pharmaceuticals Corporation, Merck KGaA and Stallergenes Greer plc
- Allergy Therapeutics Plc is a biopharmaceutical company that specializes in developing immunotherapy products for the treatment of allergies, including birch allergy. The company has developed a range of products for the treatment of birch allergy, including subcutaneous and sublingual immunotherapies.
- Desentum’s product for birch allergy is called ASIT+TM Birch, which is a vaccine that combines Desentum’s proprietary peptide-based technology with an adjuvant to enhance the immune response.
More Valuable Insights
Future Market Insights, in its new offering, presents an unbiased analysis of the global Birch allergy treatment market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.
Request Your Customized Report Now! https://www.futuremarketinsights.com/customization-available/rep-gb-16769
The study reveals essential insights based on Drug Class (Antihistamines, Cetirizine, Diphenhydramine, Decongestant, Pseudoephedrine, Oxymetazoline) Route of Administration (Oral, Intranasal), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) Region (North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East & Africa)
Key Segments Profiled in the Global Birch Allergy Treatment Industry Survey
Drug Class:
- Antihistamines
- Cetirizine
- Diphenhydramine
- Decongestant
- Pseudoephedrine
- Oxymetazoline
Route of Administration:
- Oral
- Intranasal
Distribution Channel:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube